(Q44606314)

4 December 2017

title

Epidemiological risk factors for hypersensitivity reactions to abacavir (English)

1 reference

4 December 2017

Epidemiological risk factors for hypersensitivity reactions to abacavir* (English)

1 reference

https://api.crossref.org/works/10.1046/J.1468-1293.2003.00166.X

17 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1468-1293.2003.00166.X

17 March 2024

1

P. J. Easterbrook

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

4

N. Ives

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

7

A. Vyakarnam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

8

D. Thorburn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

author name string

A. Waters

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

S. Murad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

C. Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

D. King

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

17 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14525543

17 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1468-1293.2003.00166.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525543

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1468-1293.2003.00166.x

17 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1468-1293.2003.00166.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1468-1293.2003.00166.x

17 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1468-1293.2003.00166.X

17 March 2024

1 reference

4 December 2017

volume

4

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

321-324

1 reference

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00166.X

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00166.X

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00166.X

Female sex but not ethnicity is a strong predictor of non-nucleoside reverse transcriptase inhibitor-induced rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00166.X

Sex differences in nevirapine rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00166.X

Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1293.2003.00166.X

21 January 2018

Identifiers

1 reference

4 December 2017

1 reference